TMCI
Treace Medical·NASDAQ
--
--(--)
--
--(--)
1.11 / 10
Underperform
Fundamental analysis reveals TMCI in a weak position, scoring only 1.1/10. Critical concerns are negative differences in revenue and asset value relative to market peers, a low net profit margin, and a negative ROA. Favorable aspects are limited to cash-to-market value and interest coverage ratio, but these are insufficient to offset the broader weaknesses, leading to a defensive fundamental rating.
Analysis Checks(6/10)
Revenue-MV
Value-0.29
Score0/3
Weight22.92%
1M Return-3.84%
Value-0.29
Score0/3
Weight22.92%
1M Return-3.84%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.50%
1M Return-1.71%
Value100.00
Score2/3
Weight10.50%
1M Return-1.71%
Cash-UP
Value-0.06
Score2/3
Weight25.61%
1M Return-4.86%
Value-0.06
Score2/3
Weight25.61%
1M Return-4.86%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight11.84%
1M Return-1.95%
Value15.48
Score2/3
Weight11.84%
1M Return-1.95%
Cash-MV
Value-0.07
Score2/3
Weight-26.46%
1M Return3.31%
Value-0.07
Score2/3
Weight-26.46%
1M Return3.31%
ROA (%)
Value-23.98
Score2/3
Weight2.42%
1M Return-0.39%
Value-23.98
Score2/3
Weight2.42%
1M Return-0.39%
Net income-Revenue
Value-0.17
Score1/3
Weight14.83%
1M Return-2.55%
Value-0.17
Score1/3
Weight14.83%
1M Return-2.55%
Annualized net profit margin on total assets (%)
Value-31.98
Score2/3
Weight2.42%
1M Return-0.39%
Value-31.98
Score2/3
Weight2.42%
1M Return-0.39%
Asset-MV
Value-0.50
Score0/3
Weight19.84%
1M Return-3.57%
Value-0.50
Score0/3
Weight19.84%
1M Return-3.57%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight16.06%
1M Return-2.89%
Value100.00
Score1/3
Weight16.06%
1M Return-2.89%
Revenue-MV
Value-0.29
Score0/3
Weight22.92%
1M Return-3.84%
Value-0.29
Score0/3
Weight22.92%
1M Return-3.84%
ROA (%)
Value-23.98
Score2/3
Weight2.42%
1M Return-0.39%
Value-23.98
Score2/3
Weight2.42%
1M Return-0.39%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.50%
1M Return-1.71%
Value100.00
Score2/3
Weight10.50%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight14.83%
1M Return-2.55%
Value-0.17
Score1/3
Weight14.83%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight25.61%
1M Return-4.86%
Value-0.06
Score2/3
Weight25.61%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-31.98
Score2/3
Weight2.42%
1M Return-0.39%
Value-31.98
Score2/3
Weight2.42%
1M Return-0.39%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight11.84%
1M Return-1.95%
Value15.48
Score2/3
Weight11.84%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight19.84%
1M Return-3.57%
Value-0.50
Score0/3
Weight19.84%
1M Return-3.57%
Cash-MV
Value-0.07
Score2/3
Weight-26.46%
1M Return3.31%
Value-0.07
Score2/3
Weight-26.46%
1M Return3.31%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight16.06%
1M Return-2.89%
Value100.00
Score1/3
Weight16.06%
1M Return-2.89%
Is TMCI undervalued or overvalued?
- TMCI scores 1.11/10 on fundamentals and holds a Premium valuation at present. Backed by its -49.10% ROE, -22.89% net margin, -2.90 P/E ratio, 1.60 P/B ratio, and 19.19% earnings growth, these metrics solidify its Underperform investment rating.
